ArticleJournal of translational medicine2025

TRIML2 promotes malignant progression of head and neck squamous cell carcinoma via canonical Wnt signaling and tumor immune escape.

Xi Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.